Connection

DIHUA YU to Poly(ADP-ribose) Polymerase Inhibitors

This is a "connection" page, showing publications DIHUA YU has written about Poly(ADP-ribose) Polymerase Inhibitors.
  1. Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex. Nat Cancer. 2022 10; 3(10):1211-1227.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.